Utility of cystatin C for assessment of renal function after cardiac surgery

D Heise1, R M Waeschle, J Schlobohm

  • 1Department of Anaesthesiology, Emergency and Intensive Care Medicine, University of Gottingen, Gottingen, Germany. dheise1@gwdg.de

Insights

Serum creatinine and cystatin C (CysC) equally detect reduced kidney function in cardiac surgery patients. However, serum creatinine is more effective for detecting milder kidney function decline, showing no superiority for CysC in GFR assessment.

Area of Science:

  • Nephrology
  • Cardiovascular Surgery
  • Clinical Chemistry

Background:

  • Acute kidney injury in cardiac surgery increases mortality.
  • Early diagnosis of renal failure is challenging due to delayed lab markers.
  • Glomerular filtration rate (GFR) estimation using cystatin C (CysC) shows inconsistent results compared to serum creatinine.

Purpose of the Study:

  • Compare the diagnostic effectiveness of serum creatinine and CysC for GFR assessment in cardiac surgery patients.
  • Evaluate the sensitivity and specificity of both markers in detecting reduced GFR.
  • Assess the correlation between estimated GFR and creatinine clearance.

Main Methods:

  • GFR was measured via creatinine clearance in 50 cardiac surgery patients.
  • GFR was estimated using serum creatinine and CysC concentrations.
  • Sensitivity, specificity, and correlation analyses were performed.

Main Results:

  • Both creatinine and CysC equally detected GFR <60 ml/min/1.73 m(2).
  • Serum creatinine demonstrated higher accuracy (AUC) for detecting GFR <90 ml/min/1.73 m(2).
  • Creatinine-based formulas showed a stronger correlation with creatinine clearance.

Conclusions:

  • Serum creatinine is not inferior to CysC for GFR assessment in post-cardiac surgery patients.
  • CysC offers no significant advantage over serum creatinine in this patient population.
  • Serum creatinine remains a reliable marker for monitoring kidney function after cardiac surgery.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...